StonvexLoading…
StonvexStonvexStonvexCore line items from CRVL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $895.59M | $795.31M | $202.30M | $195.52M |
Operating Income | $120.82M | $95.10M | Not available | Not available |
Net Income | $95.17M | $76.25M | $17.09M | $19.90M |
EPS (Diluted) | $1.83 | $1.47 | $0.99 | $1.15 |
Total Assets | $545.98M | $454.68M | Not available | Not available |
Total Liabilities | $223.99M | $207.03M | Not available | Not available |
Cash & Equivalents | $170.58M | $105.56M | Not available | Not available |
Free Cash Flow OCF − CapEx | $91.56M | $70.00M | Not available | Not available |
Shares Outstanding | 51.36M | 51.39M | Not available | Not available |